Cargando…
Nonfasting Apo-lipoprotein B and Triglyceride levels as a predictor of coronary heart disease in Type II diabetic patients
BACKGROUND & OBJECTIVES: Lipoprotein-A has been recognized as a risk factor for ischemic heart diseases. Myocardial infarction (MI) is common complication of ischemic heart disease. Diabetes play an incremental role in the development of coronary artery disease (CAD), however still there are con...
Autores principales: | Nayyer-uz-Zaman, Dar, Muhammad Habeel, Adnan, Yasir, Noor, Lubna, Naz, Gul, Zahoor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Professional Medical Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954359/ https://www.ncbi.nlm.nih.gov/pubmed/29805388 http://dx.doi.org/10.12669/pjms.342.13848 |
Ejemplares similares
-
Impact of stent length and diameter on short term clinical outcomes of drug eluting stents in patients with stable coronary artery disease
por: Adnan, Yasir, et al.
Publicado: (2017) -
Short term clinical outcomes of Everolimus-eluting stents in patients with stable angina pectoris
por: Dar, Muhammad Habeel, et al.
Publicado: (2018) -
Nonfasting triglycerides and risk of cardiovascular death in men and women from the Norwegian Counties Study
por: Lindman, Anja S., et al.
Publicado: (2010) -
The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
por: Borén, Jan, et al.
Publicado: (2020) -
Novel Aspects of Nonfasting Lipemia in relation to Vascular Biology
por: Castro Cabezas, M., et al.
Publicado: (2012)